MYGN

NEW IDEA ON MYRIAD GENETICS, THE INVENTOR OF BREAST CANCER GENETIC TEST $MYGN $LH $DGX

This post was just published on ZYX Short Change Alert. MYGN’s claim to fame is a test to identify BRCA mutations that increase the risk of breast and ovarian cancers.  Previously, DGX announced plans to compete with MYGN. Today LH announced the nationwide availability of a suite of tests to identify

Read More

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence